News & Publications

Press Releases

MCRA Assists NeuroMetrix with Obtaining FDA Breakthrough Device Designation and Marketing Authorization in One Year

Read Article

Jul — 2022

Publications

Compliance Flash: Physician Owned Distributorship

Read Article

Jul — 2022

Press Releases

MCRA and Clients Achieve Significant Milestone - Over 60 Breakthrough Device Designations Granted by FDA

Read Article

Jun — 2022

Press Releases

MCRA Assists BONESUPPORT AB with the First Ever Combination Product DeNovo Decision Granted by the U.S. FDA

Read Article

Jun — 2022

Press Releases

MCRA Assists Net Health in Receiving Breakthrough Device Status

Read Article

Jun — 2022

Publications

Compliance Flash: Single Use Devices

Read Article

Jun — 2022

Press Releases

MCRA Acquires Vorpal Technologies K.K. to Further Expand its Global Advisory Services in Japan

Read Article

Mar — 2022

Publications

Risk Management is critical to establishing a positive benefit: risk profile and ensuring the best possible patient outcomes. By: Peter Bowness Director, International Regulatory Affairs

Read Article

Jan — 2022

Press Releases

MCRA Assists Active Life Scientific with Clinical Study Execution and Successful De Novo Decision for the OsteoProbe - A New Tool to Measure Bone Tissue

Read Article

Jan — 2022

Press Releases

MCRA Assists Multiple Clients with Successfully Obtaining CPT Codes and Hospital Payment Reassignments

Read Article

Jan — 2022

Press Releases

MCRA Neuro CRO Division Strengthened

Read Article

Nov — 2021

Press Releases

MCRA Expands Neurology Division into Medical Robotics, Exoskeletal and Brain Computer Interface Market

Read Article

Oct — 2021

Press Releases

MCRA Hires Melissa Paper, JD, MPA, CHC as Vice President of Healthcare Compliance

Read Article

Oct — 2021

Press Releases

MCRA Expands Neurology Division into Neurointerventional Market

Read Article

Sep — 2021

Press Releases

MCRA Expands In-Vitro Diagnostic Device Expertise

Read Article

Jul — 2021

Webinars

Considerations for Orthopedic Implant Associated Antimicrobial Agents: Regulatory Science

Read Article

Jun — 2021

News & Publications

Filter By:

MCRA Assists NeuroMetrix with Obtaining FDA Breakthrough Device Designation and Marketing Authorization in One Year

Compliance Flash: Physician Owned Distributorship

MCRA and Clients Achieve Significant Milestone - Over 60 Breakthrough Device Designations Granted by FDA

MCRA Assists BONESUPPORT AB with the First Ever Combination Product DeNovo Decision Granted by the U.S. FDA

MCRA Assists Net Health in Receiving Breakthrough Device Status

Compliance Flash: Single Use Devices

MCRA Acquires Vorpal Technologies K.K. to Further Expand its Global Advisory Services in Japan

Risk Management is critical to establishing a positive benefit: risk profile and ensuring the best possible patient outcomes. By: Peter Bowness Director, International Regulatory Affairs

MCRA Assists Active Life Scientific with Clinical Study Execution and Successful De Novo Decision for the OsteoProbe - A New Tool to Measure Bone Tissue

MCRA Assists Multiple Clients with Successfully Obtaining CPT Codes and Hospital Payment Reassignments

MCRA Neuro CRO Division Strengthened

MCRA Expands Neurology Division into Medical Robotics, Exoskeletal and Brain Computer Interface Market

MCRA Hires Melissa Paper, JD, MPA, CHC as Vice President of Healthcare Compliance

MCRA Expands Neurology Division into Neurointerventional Market

MCRA Expands In-Vitro Diagnostic Device Expertise

Considerations for Orthopedic Implant Associated Antimicrobial Agents: Regulatory Science

Newsletter Signup